SCHEMBL21811824

SCHEMBL21811824

O=CCc1c(F)ccc(Cl)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.36
MEP1A Q16819 1/20 0.35
MEP1B Q16820 1/20 0.35
DPP4 P27487 1/20 0.34
GAA P10253 1/20 0.33
CNR1 P21554 1/20 0.33
PIK3CA P42336 1/20 0.33
BACE1 P56817 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
MAPT P10636 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TP53 P04637 1/20 0.31
SLC2A1 P11166 1/20 0.31
KMT2A Q03164 2/20 0.31
ERCC1 P07992 1/20 0.31
ERCC4 Q92889 1/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21812009 0.84 DPP4 (0.39) ERN1MEP1AMEP1BDPP4MAPT
SCHEMBL18191222 0.81 GABRA1 (0.35) MEP1AMEP1BDPP4GAACNR1
SCHEMBL12825475 0.81 MPO (0.35) GAACNR1BACE1KDM4ETAAR1
SCHEMBL29447983 0.81 MPO (0.35) GAACNR1BACE1KDM4ETAAR1
SCHEMBL21811819 0.81 CYP3A4 (0.37) ERN1MEP1AMEP1BDPP4PIK3CA
SCHEMBL21822850 0.79 HTR3E (0.36) MEP1BDPP4GAAKDM4EMAPT
SCHEMBL430975 0.78 ERN1 (0.36) ERN1MEP1AMEP1BAR
SCHEMBL22031845 0.78 TAAR1 (0.32) GAACNR1TAAR1SMN1; SMN2
SCHEMBL21811818 0.78 DPP4 (0.34) ERN1MEP1AMEP1BDPP4MAPT
SCHEMBL29457672 0.78 TAAR1 (0.32) GAACNR1TAAR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3849966-A1 FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. Hoffmann-La Roche AG (CH) 2021-07-21 EP disclosed
WO-2020053249-A1 FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 WO disclosed